Skip to content
Open access

Prevalence and factors associated with the development of asthma in a cohort of children who were preterm infants and received passive immunization with palivizumab

Oct 2026 · Respiratory Research & Clinical Practice · 0 citations · 28 references

Abstract

Objective: To assess the prevalence of asthma in a cohort of preterm infants, comparing those who received prophylaxis with palivizumab, a monoclonal antibody against respiratory syncytial virus (RSV), with those who did not. That is relevant because RSV infection has been linked to recurrent wheezing and asthma in childhood, but a causal relationship remains unclear. Methods: This was a prospective cohort study involving children who were preterm infants without congenital heart disease, exposed or not to palivizumab. Parents or legal guardians answered a telephone questionnaire adapted from the International Study of Asthma and Allergies in Childhood, which covers respiratory symptoms, allergy history, and potential risk factors. Results: Among 292 eligible children, 217 were included (149 in the palivizumab group and 68 in the control group). Of those 217 infants, 25.3% (95% CI:19.9-31.5%) had asthma: 24.2% (95% CI: 17.8-31.5%) in the palivizumab group and 27.9% (95% CI: 18.3-39.5%) in the control group, with no significant difference (p = 0.553). In the bivariate analysis, asthma was significantly associated with a family history of atopy (p < 0.001), parental asthma (p = 0.006), allergic rhinitis in the child (p < 0.001), and atopic dermatitis in the child (p = 0.022). In the multivariate analysis, asthma remained associated with a family history of atopy (adjusted OR = 4.16; 95% CI: 1.77-9.79), allergic rhinitis in the child (adjusted OR = 5.10; 95% CI: 2.59-10.02), and parental asthma (adjusted OR = 2.45; 95% CI: 1.19- 5.04). Conclusions: Palivizumab does not seem to protect against asthma development in preterm infants without congenital heart disease. A family history of atopy, parental asthma, and allergic rhinitis in the child seem to be the primary determinants of asthma risk in such infants.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.